Immunology Core
Immunology Core
批准号:
7667903
负责人:
John David Altman
金额:
$38.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2012-07-31
关键词:
AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAdoptionAdvertisingAntibodiesArtsBiological AssayBoxingCategoriesCell SeparationCellsCellular AssayCellular ImmunityChargeChimeric ProteinsClinical TrialsColorCommunitiesComputer AnalysisComputer softwareCustomDataData AnalysesDevelopmentEnvironmentFlow CytometryGrantHIVHearingHumanImmunologic Deficiency SyndromesImmunologic TechniquesImmunologyIn VitroIndividualInternationalInternational AIDSLabelLaboratoriesLibrariesMediatingMissionMonkeysMonoclonal AntibodiesNIH Program AnnouncementsPathogenesisPerformancePeripheral Blood Mononuclear CellPreventionPricePrimatesProductionPurposeReagentResearchResearch PersonnelResource SharingResourcesSamplingScientistServicesSorting - Cell MovementStaining methodStainsStandardizationTrainingTraining and EducationVaccinatedValidationVirus DiseasesVisitWorkassay developmentcell mediated immune responsechemokinecytokinedata acquisitiondesignimmune functionin vivoinnovationinstrumentinstrumentationmembermethod developmentmicrobialmultidisciplinarynonhuman primatenovelpathogenpre-clinicalrepositoryresearch studytherapeutic vaccinevaccine developmentvaccine efficacy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Under the direction of Dr. John D. Altman, the mission of Core H, the Emory CFAR Immunology Core
Laboratory (ICL), is to provide the Emory community with the highest quality assessments of immunological
function necessary for the study of the pathogenesis, treatment, and prevention of immunodeficiency virus
infections in humans and non-human primates. The ICL will achieve this mission through the following
Specific Aims:
1. Develop and perform optimized, standardized, and validated assays of cellular immune function in
vaccinated subjects, in HIV-infected humans, and in SIV-infected non-human primates (NHP);
2. Create a repository of cryopreserved PBMC from naive (off-study) monkeys from the Yerkes
Primate Research Center, thereby providing CFAR investigators with access to esse'ntial negative control
samples for assay development and validation.
3. Achieve economies of scale through the provision of immunological reagent resources shared by
multiple independent laboratories;
4. Maintain a CFAR Flow Cytometry Core, for the purpose of providing members of the Emory CFAR, and
the larger AIDS research community, with the highest quality flow cytometry data and cell sorting
services available, including handling of biohazardous samples;
5. Promote immunological assay education and training opportunities for CFAR investigators, the
AIDS research community in Atlanta, and national and international AIDS investigators.
Through these Aims, the ICL will enable all Emory CFAR investigators to take advantage of innovative and
powerful modern approaches to quantitative analysis of innate and acquired humoral and cell-mediated
immunity that have been developed by individual Emory investigators and scientists elsewhere. Accurate
characterization of cell-mediated immune responses is essential for guiding preclinical vaccine development,
for determining possible correlates of vaccine efficacy in preclinical and clinical trials, and for better
understanding AIDS pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INFLUENZA PATHOGENESIS AND IMMUNOLOGY RESEARCH CENTER:T CELL RESPONSES
-
批准号:8357561
-
项目类别:
-
资助金额:$12.34万
-
财政年份:2011
-
负责人:John David Altman
-
依托单位:
MECHANISMS OF HELP FOR CD8 T CELL RESPONSES
-
批准号:8357482
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:John David Altman
-
依托单位:
NIAID TETRAMER FACILITY
-
批准号:8357391
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:John David Altman
-
依托单位:
Enhancing the Immunogenicity and Utility of MVA-Based AIDS Vaccines
-
批准号:8075652
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:John David Altman
-
依托单位:
THE ROLE OF LEUKOCYTE SEQUESTRATION IN THE CONTROL OF VIRALINFECTIONS
-
批准号:8172445
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:John David Altman
-
依托单位:
Enhancing the Immunogenicity and Utility of MVA-Based AIDS Vaccines
-
批准号:7927768
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2010
-
负责人:John David Altman
-
依托单位:
CONTROLLING HIV/SIV WITH DRUGS THAT MANIPULATE LYMPHOCYTE TRAFFICKING
-
批准号:8172439
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:John David Altman
-
依托单位:
NIAID TETRAMER FACILITY
-
批准号:8172320
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:John David Altman
-
依托单位:
OPTIMIZE THE IMMUNOGENICITY OF MVA-BASED AIDS VACCINES
-
批准号:7958169
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2009
-
负责人:John David Altman
-
依托单位:
THE ROLE OF LEUKOCYTE SEQUESTRATION IN THE CONTROL OF VIRALINFECTIONS
-
批准号:7958273
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2009
-
负责人:John David Altman
-
依托单位:
NIAID TETRAMER FACILITY
-
批准号:7958122
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2009
-
负责人:John David Altman
-
依托单位:
CONTROLLING HIV/SIV WITH DRUGS THAT MANIPULATE LYMPHOCYTE TRAFFICKING
-
批准号:7958266
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2009
-
负责人:John David Altman
-
依托单位:
The Role of Leukocyte Sequestration in the Control of Viral Infections
-
批准号:7681404
-
项目类别:
-
资助金额:$43.37万
-
财政年份:2008
-
负责人:John David Altman
-
依托单位:
NIAID TETRAMER FACILITY
-
批准号:7715687
-
项目类别:
-
资助金额:$6.8万
-
财政年份:2008
-
负责人:John David Altman
-
依托单位:
DEVELOPMENT OF NOVEL T CELL ASSAYS
-
批准号:7658458
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2008
-
负责人:John David Altman
-
依托单位:
The Role of Leukocyte Sequestration in the Control of Viral Infections
-
批准号:7826196
-
项目类别:
-
资助金额:$43.37万
-
财政年份:2008
-
负责人:John David Altman
-
依托单位:
OPTIMIZE THE IMMUNOGENICITY OF MVA-BASED AIDS VACCINES
-
批准号:7715743
-
项目类别:
-
资助金额:$6.8万
-
财政年份:2008
-
负责人:John David Altman
-
依托单位:
Immunology Core
-
批准号:7279021
-
项目类别:
-
资助金额:$36.05万
-
财政年份:2007
-
负责人:John David Altman
-
依托单位:
T CELL REPERTOIRES SPECIFIC FOR DEFINED VIRAL EIPTOPES
-
批准号:7562522
-
项目类别:
-
资助金额:$6.55万
-
财政年份:2007
-
负责人:John David Altman
-
依托单位:
EVALUATION OF CELLULAR IMMUNITY INDUCED BY HIV VACCINES
-
批准号:7562527
-
项目类别:
-
资助金额:$6.55万
-
财政年份:2007
-
负责人:John David Altman
-
依托单位:
海外基金